JAPAN USA CHINA


Price & Availability : Please Select your country

 

Carboxy-PTIO

Item # Unit Size
C348-10
10 mg

For Research Use Only Products

Application:NO quenching, NO detection by ESR


MSDS

Chemical Name: 2-(4-Carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide, sodium salt
CAS: 148819-93-6

Appearance: Dark blue or black powder
MW: 299.28, C14H16N2NaO4

Storage Condition: -20ºC, protect from light, moisture and metal
Shipping Condition: ambient temperature

Product Description
Carboxy-PTIO is a stable, water-soluble organic radical that reacts with NO to form NO2· This reaction can be monitored by electron spin resonance (ESR). NO is an unstable molecule and has a complex reaction cascade for its metabolism in biological systems. Rapidly generated NO-related metabolites carry out various physiological activities. Commonly used NO scavengers such as hemoglobin trap NO; they also trap NOS inhibitors such as arginine derivatives. These NO scavengers also quench all other NO-related metabolites at the same time. In contrast, Carboxy-PTIO does not dramatically affect other NO-related product systems because it transforms NO to NO2, which is a metabolite of NO. Thus, Carboxy-PTIO can be used to investigate the effects of NO separately from its downstream metabolites. Dr. Akaike and others showed that Carboxy-PTIO suppresses relaxation of the rat aorta ring, which is induced by acetylcholine, twice as effectively as NG-nitroarginine. Dr. Yoshida and others reported that downstream metabolites of NO, generated by treatment with Carboxy-PTIO, have an increased antiviral activity compared to NO alone. The NO metabolites play important roles in biological systems; therefore, they should be investigated separately from NO.


Reaction of NO quenching

References
1. E. F. Ullman, et al., Studies of Stable Free Radicals. X. Nitronyl Nitroxide Monoradicals and Biradicals as Possible Small Molecule Spin Labels. J Am Chem Soc. 1972;94:7049-7059.
2. Y. Miura, et al., Polymers Containing Stable Free Raficals, 5. Preparation of a Polymer Containing Imidazoline 3-Oxide 1-Oxyl Groups. Macromol Chem Phys. 1973;172:233-236.
3. K. Inoue, et al., Magnetic Properties of the Crystals of p-(1-Oxyl-3-Oxide-4, 4, 5, 5-Tetramethyl-2-Imidazolin-2-Yl)Benzoic acid and Its Alkali Metal Salts. Chem Phys Lett. 1993;207:551-555.
4. T. Akaike, et al., Antagonistic Action of Imidazolineoxyl N-Oxides Against Endothelium-Derived Relaxing Factor/NO Through a Radical Reaction. Biochemistry. 1993;32:827-832.
5. J. Joseph, et al., Trapping of Nitric Oxide by Nitronyl Nitroxides: an Electron Spin Resonance Investigation. Biochem Biophys Res Commun. 1993;192:926-934.
6. M. Yoshida, et al., Therapeutic Effects of Imidazolineoxyl N-Oxide Against Endotoxin Shock Through Its Direct Nitric Oxide-scavenging Activity. Biochem Biophys Res Commun. 1994;202:923-930.
7. T. Az-Ma, et al., Reaction Between Imidazolineoxil N-Oxide(Carboxy-PTIO) and Nitric Oxide Released from Cultured Endothelial Cells:Quantitative Measurement of Nitric Oxide by ESR Spectrometry. Life Sci. 1994;54:PL185-PL190.
8. H. Maeda, et al., Multiple Functions of Nitric Oxide in Pathophysiology and Microbiology: Analysis by a New Nitric Oxide Scavenger. J Leukoc Biol. 1994;56:588-592.
9. T. Akaike, et al., Quantitation of Nitric Oxide Using 2-Phenyl-4, 4, 5, 5-Tetramethylimidazoline-1-Oxyl 3-Oxide(PTIO). Methods Enzymol. 1996;268:211-221.
10. S. Satoh, et al., NO Donors Stimulate Noradrenaline Release from Rat Hippocampus in a Calmodulin-dependent Manner in the Presence of LCysteine. J Cell Physiol. 1996;169:87-96.
11. D. C. Hooper, et al., Prevention of Experimental Allergic Encephalomyelitis by Targeting Nitric Oxide and Peroxynitrite: Implications for the Treatment of Multiple Sclerosis. PNAS. 1997;94:2528-2533.
12. S. Pfeiffer, et al., Interference of carboxy-PTIO with Nitric-Oxide and Peroxynitrite-Mediated Reactions. Free Radic Biol Med. 1997;22:787-794.